Giuseppe Mangialardi

Giuseppe Mangialardi

UNVERIFIED PROFILE

Are you Giuseppe Mangialardi?   Register this Author

Register author
Giuseppe Mangialardi

Giuseppe Mangialardi

Publications by authors named "Giuseppe Mangialardi"

Are you Giuseppe Mangialardi?   Register this Author

29Publications

327Reads

33Profile Views

Bone marrow pericyte dysfunction in individuals with type 2 diabetes.

Diabetologia 2019 Jul 17;62(7):1275-1290. Epub 2019 Apr 17.

Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Level 7, Upper Maudlin Street, Bristol, BS2 8HW, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00125-019-4865-6
Publisher Site
http://dx.doi.org/10.1007/s00125-019-4865-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560025PMC
July 2019

Correction to: Bone marrow pericyte dysfunction in individuals with type 2 diabetes.

Diabetologia 2019 Jul;62(7):1315

Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Level 7, Upper Maudlin Street, Bristol, BS2 8HW, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00125-019-4902-5
Publisher Site
http://dx.doi.org/10.1007/s00125-019-4902-5DOI Listing
July 2019

Pericytes, an overlooked player in vascular pathobiology.

Pharmacol Ther 2017 03 1;171:30-42. Epub 2016 Dec 1.

Division of Experimental Cardiovascular Medicine, School of Clinical Sciences, Bristol Heart Institute, University of Bristol, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2016.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008604PMC
March 2017

The bone marrow pericyte: an orchestrator of vascular niche.

Regen Med 2016 12 25;11(8):883-895. Epub 2016 Nov 25.

Division of Experimental Cardiovascular Medicine, Bristol Heart Institute, University of Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/rme-2016-0121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677781PMC
December 2016

New vascular endothelial growth factor isoforms promise to increase myocardial perfusion without stealing.

Heart 2016 11 26;102(21):1697-1698. Epub 2016 Jul 26.

Bristol Heart Institute, School of Clinical Sciences University of Bristol Level 7, Bristol Royal Infirmary, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2016-309845DOI Listing
November 2016

Diabetes Stimulates Osteoclastogenesis by Acidosis-Induced Activation of Transient Receptor Potential Cation Channels.

Sci Rep 2016 07 29;6:30639. Epub 2016 Jul 29.

Division of Experimental Cardiovascular Medicine, Bristol Heart Institute, University of Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep30639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965751PMC
July 2016

Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications.

Curr Diab Rep 2016 May;16(5):43

Bristol Heart Institute, University of Bristol, Level 7, Bristol Royal Infirmary, Upper Maudlin Street, Bristol, BS28HW, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-016-0730-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819731PMC
May 2016

Enhancing Stem Cell Mobility: New Hope for Treatment of Cardiovascular Complications in Patients With Diabetes?

Diabetes 2015 Aug;64(8):2704-7

Bristol Heart Institute, University of Bristol, Bristol, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db15-0433DOI Listing
August 2015

Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.

Circ Res 2015 May 23;116(10):e81-94. Epub 2015 Mar 23.

From the Experimental Cardiovascular Medicine (E.A., H.L.S., F.R., R.K., G.M., A.O., I.R.-A., Z.D., K.M., C.R., V.V.A., J.R., P.M.) and Vascular Pathology and Regeneration (M.M., C.E.), School of Clinical Sciences, University of Bristol, Bristol, United Kingdom; Institute of Cardiovascular and Medical Sciences (M.M.), University of Glasgow, Glasgow, United Kingdom; Department of Physiology, University of Otago, Dunedin, New Zealand (R.K.); Department of Medical and Biological Sciences (D.C., A.P.B.) and Department of Experimental Medical and Clinical Sciences (U.L.), University of Udine, Udine, Italy; and Cardiac Surgery, Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom (G.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.115.306146DOI Listing
May 2015

Epigenetic profile of human adventitial progenitor cells correlates with therapeutic outcomes in a mouse model of limb ischemia.

Arterioscler Thromb Vasc Biol 2015 Mar 8;35(3):675-88. Epub 2015 Jan 8.

From the Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, UK (M.G., S.C.S., H.L.S., F.R., J.R., E.A., R.K., G.M., A.O., C.R., C.E., G.A., P.M.); The Institute of Cancer Research, Evolutionary Genomics and Modelling Team, Centre for Evolution and Cancer, Sutton, UK (I.S., A.S.); Imperial College, London, UK (P.C., C.E., G.A.); MultiMedica Research Institute, Milan, Italy (G.S.); Cancer Research UK Cambridge Institute, Cambridge, UK (A.T., S.T.); Centro Cardiologico Monzino, Milan, Italy (F.P., M.P.); and Austrian Institute of Technology, Vienna, Austria (M.H., V.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.114.304989DOI Listing
March 2015

Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2.

Arterioscler Thromb Vasc Biol 2015 Mar 22;35(3):664-74. Epub 2015 Jan 22.

From the Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom (I.F., B.D., A.V., T.M., S.S., G.S.-N., G.M., L.H., C.E.); Laboratory of Vascular Biology, Department of Biomedical Science (I.F., A.V., M.P., G.P.) and Department of Obstetrics and Gynecology Unit (G.C., S.D.), University of Sassari, Sassari, Italy; Laboratory of Epigenetics and Chromatin Dynamics, Mayo Clinic, Rochester, MN (R.U.); and National Heart and Lung Institute, Imperial College London, London, United Kingdom (C.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.114.304730DOI Listing
March 2015

Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes.

Antioxid Redox Signal 2014 Oct;21(11):1620-33

1 Regenerative Medicine Section, Bristol Heart Institute, School of Clinical Sciences, University of Bristol , Bristol, United Kingdom .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/ars.2014.5944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175424PMC
October 2014

Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.

Arterioscler Thromb Vasc Biol 2013 Mar 10;33(3):555-64. Epub 2013 Jan 10.

Experimental Cardiovascular Medicine, Regenerative Medicine Section Bristol Heart Institute, School of Clinical Sciences University of Bristol, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.112.300424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616369PMC
March 2013

A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents.

Int J Clin Exp Med 2013 18;6(1):30-8. Epub 2012 Nov 18.

Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School Bari, Italy.

View Article

Download full-text PDF

Source
http://www.ijcem.com/files/IJCEM1210008.pdf
Web Search
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515976PMC
December 2012

Antiangiogenic therapeutic approaches in multiple myeloma.

Curr Cancer Drug Targets 2012 Sep;12(7):768-75

Department of Basic Medical Sciences, Section of Human Anatomy and Histology, University of Bari Medical School, Piazza Giulio Cesare, 11, Bari, Italy.

View Article

Download full-text PDF

Source
September 2012

Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.

Stem Cells Int 2012 31;2012:607260. Epub 2012 May 31.

Section of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Policlinico, Piazza Giulio Cesare 11, I-70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/607260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369512PMC
August 2012

Bone marrow microenvironment: a newly recognized target for diabetes-induced cellular damage.

Endocr Metab Immune Disord Drug Targets 2012 Jun;12(2):159-67

Chair of Experimental Cardiovascular Medicine, Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, UK.

View Article

Download full-text PDF

Source
June 2012

Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma.

Mol Cancer Ther 2007 Dec;6(12 Pt 1):3256-62

Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Policlinico, Piazza Giulio Cesare, 11, I-70124 Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0311DOI Listing
December 2007